Chek Meng Poh

A committed senior research scientist with over 7+ years of experience in managing biological and biomedical research projects. I strive to leverage my strength in T cell and cancer immunology to foster creative solutions that helps in solving global challenges.

2021-2023: Senior Research Scientist, Tessa Therapeutics Ltd
Pre-clinical research of CAR-T cells in solid tumors to enhance activity and persistence. Created multiple cell lines with CRISPR and transduction that accelerates CAR-T cell research.

2019-2021: Research Fellow, Singapore Immunology Network, A*STAR
Developing optimized serological assay to study COVID-19 antibodies in patient samples. Further modified targets of multiplex cytotoxicity assay into limitless cell line version.

2016-2019: A*STAR International Fellow, School of Public Health, University of Hong Kong Developing multiplex cytotoxicity assay to investigate role of tissue-resident memory T cells in combating influenza.

2011-2015: PhD candidate, Singapore Immunology Network, A*STAR; Department of Microbiology and Immunology, National University of Singapore
Investigating mechanisms of pathogenic CD8 T cells in mouse models of cerebral malaria

2010-2011: Research Officer, Singapore Immunology Network, A*STAR
Generating cDNA plasmid and cell line library to study pathogenic CD8 T cells in mouse models of cerebral malaria

National University of Singapore, PhD, Microbiology and Immunology (2015) 

Nanyang Technological University, BSc (2nd Class Upper), Biological Sciences (2011)